tiprankstipranks
Trending News
More News >
Advertisement

DHS - ETF AI Analysis

Compare

Top Page

DHS

WisdomTree U.S. High Dividend Fund (DHS)

Rating:71Outperform
Price Target:
DHS, the WisdomTree U.S. High Dividend Fund, earns a solid overall rating, helped by strong, diversified leaders like Merck, Verizon, and PepsiCo, which show robust financial performance, healthy cash flows, and promising pipelines or strategic initiatives. Energy giants like Exxon Mobil and Chevron, along with telecom names AT&T and Verizon, support the income and value profile but bring risks tied to debt levels, bearish technical signals, and sector-specific challenges, so investors should be aware that the fund is somewhat concentrated in a few high-dividend sectors such as energy, telecom, and healthcare.
Positive Factors
Solid Recent Performance
The fund has shown steady gains over the past month, three months, and year to date, indicating positive recent momentum.
Strong Top Dividend Names
Several of the largest holdings, including major energy, consumer, and technology companies, have delivered strong year-to-date performance that supports the fund’s returns.
Diversified Sector Mix
Holdings are spread across financials, consumer defensive, health care, energy, utilities, and other sectors, which helps reduce the impact if any one industry struggles.
Negative Factors
High U.S. Concentration
Almost all assets are invested in U.S. companies, offering little geographic diversification if the U.S. market weakens.
Mixed Performance Among Top Holdings
A few of the largest positions, particularly in health care and communication services, have shown weak year-to-date performance that can drag on overall returns.
Above-Average Expense Ratio
The fund’s expense ratio is higher than many low-cost index ETFs, which slightly reduces the net return investors keep over time.

DHS vs. SPDR S&P 500 ETF (SPY)

DHS Summary

The WisdomTree U.S. High Dividend Fund (DHS) is an ETF that follows the WisdomTree U.S. High Dividend Index, focusing on U.S. companies that pay relatively high dividends. It holds many well-known names such as Exxon Mobil and PepsiCo, and spreads investments across sectors like financials, consumer defensive, health care, and energy. Someone might consider DHS if they want regular income from dividends and broad diversification across many stable, established companies. A key risk is that stock prices and dividend payments can go up or down with the market and with changes in company profits.
How much will it cost me?The WisdomTree U.S. High Dividend Fund (DHS) has an expense ratio of 0.38%, meaning you’ll pay $3.80 per year for every $1,000 invested. This is slightly higher than average for ETFs because it is actively managed to focus on high dividend-paying stocks, which requires more research and management. It’s designed for investors seeking income and stability through dividends.
What would affect this ETF?The WisdomTree U.S. High Dividend Fund (DHS) could benefit from stable or rising interest in dividend-paying stocks, especially during periods of economic uncertainty when investors seek reliable income sources. However, it may face challenges if interest rates rise significantly, as higher yields on bonds could make dividend-focused investments less attractive. Additionally, its heavy exposure to sectors like Health Care and Energy means it could be impacted by regulatory changes or fluctuations in commodity prices.

DHS Top 10 Holdings

This U.S.-only high-dividend fund leans heavily on classic defensives, with energy, tobacco, and big pharma doing much of the heavy lifting. Exxon Mobil and Chevron have been rising, giving the fund a strong energy backbone, while Merck and Texas Instruments add a steady mix of healthcare and tech-driven momentum. Tobacco giants Altria and Philip Morris, though facing long-term headwinds, are still pulling their weight thanks to solid recent performance and rich payouts. With telecom names like Verizon and AT&T also climbing, the fund’s income engine is running smoothly rather than racing ahead.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Exxon Mobil5.82%$82.90M$630.06B38.70%
74
Outperform
Altria Group4.94%$70.48M$111.20B15.09%
64
Neutral
AbbVie4.60%$65.51M$406.87B7.38%
66
Neutral
Philip Morris4.16%$59.31M$264.60B12.61%
61
Neutral
Merck & Company3.93%$56.00M$286.28B22.33%
80
Outperform
Chevron3.87%$55.22M$379.00B21.49%
71
Outperform
AT&T3.67%$52.31M$200.50B5.60%
71
Outperform
PepsiCo3.43%$48.95M$217.88B3.23%
78
Outperform
Verizon3.03%$43.14M$215.61B10.98%
81
Outperform
Bristol-Myers Squibb2.49%$35.43M$122.78B-1.31%
78
Outperform

DHS Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price
Price Trends
50DMA
107.87
Positive
100DMA
103.71
Positive
200DMA
99.96
Positive
Market Momentum
MACD
0.89
Positive
RSI
44.22
Neutral
STOCH
31.35
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DHS, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 112.34, equal to the 50-day MA of 107.87, and equal to the 200-day MA of 99.96, indicating a neutral trend. The MACD of 0.89 indicates Positive momentum. The RSI at 44.22 is Neutral, neither overbought nor oversold. The STOCH value of 31.35 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for DHS.

DHS Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$1.44B0.38%
71
Outperform
$8.78B0.15%
69
Neutral
$8.51B0.61%
71
Outperform
$7.47B0.07%
67
Neutral
$7.13B0.43%
73
Outperform
$1.04B0.54%
68
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
DHS
WisdomTree U.S. High Dividend Fund
109.98
14.35
15.01%
FDVV
Fidelity High Dividend ETF
FVD
First Trust Value Line Dividend Index Fund
SPYD
SPDR Portfolio S&P 500 High Dividend ETF
FDL
First Trust Morningstar Dividend Leaders Index Fund
PEY
Invesco High Yield Equity Dividend Achievers ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement